Related Experiment Video
Updated: Jun 24, 2026

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation
Published on: May 20, 2020
Atomistic insights into regulatory mechanisms of the HER2 tyrosine kinase domain: a molecular dynamics study
Shannon E Telesco1, Ravi Radhakrishnan
1Department of Bioengineering, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Abstract:
HER2 (ErbB2/Neu) is a receptor tyrosine kinase belonging to the epidermal growth factor receptor (EGFR)/ErbB family and is overexpressed in 20-30% of human breast cancers. Although several crystal structures of ErbB kinases have been solved, the precise mechanism of HER2 activation remains unknown, and it has been suggested that HER2 is unique in its requirement for phosphorylation of Y877, a key tyrosine residue located in the activation loop. To elucidate mechanistic details of kinase domain regulation, we performed molecular dynamics simulations of a homology-modeled HER2 kinase structure in active and inactive conformations. Principal component analysis of the atomistic fluctuations reveals a tight coupling between the activation loop and catalytic loop that may contribute to alignment of residues required for catalysis in the active kinase. The free energy perturbation method is also employed to predict a role for phosphorylated Y877 in stabilizing the kinase conformations. Finally, simulation results are presented for a HER2/EGFR heterodimer and reveal that the dimeric interface induces a rearrangement of the alphaC helix toward the active conformation. Elucidation of the molecular regulatory mechanisms in HER2 will help establish structure-function relationships in the wild-type kinase, as well as predict mutations with a propensity for constitutive activation in HER2-mediated cancers.
Insights
Molecular dynamics simulations reveal how HER2 (ErbB2/Neu) kinase activation is regulated. Phosphorylation of tyrosine 877 and dimerization with EGFR stabilize the active HER2 conformation, crucial for breast cancer.
Area of Science:
- Biochemistry
- Molecular Biology
- Structural Biology
Background:
- HER2 (ErbB2/Neu) is a receptor tyrosine kinase overexpressed in 20-30% of breast cancers.
- The precise activation mechanism of HER2 remains unknown, with a unique proposed requirement for Y877 phosphorylation.
Purpose of the Study:
- To elucidate mechanistic details of HER2 kinase domain regulation.
- To understand the role of Y877 phosphorylation and HER2/EGFR heterodimerization in kinase activation.
Main Methods:
- Molecular dynamics simulations of homology-modeled HER2 kinase structures.
- Principal component analysis of atomistic fluctuations.
- Free energy perturbation calculations.
Main Results:
- A tight coupling between the activation and catalytic loops in HER2 was identified.
- Phosphorylated Y877 is predicted to stabilize active kinase conformations.
- HER2/EGFR heterodimerization induces alphaC helix rearrangement towards an active conformation.
Conclusions:
- Elucidation of HER2 regulatory mechanisms aids in understanding wild-type kinase function.
- Insights can predict mutations leading to constitutive activation in HER2-mediated cancers.
Related Concept Videos
Receptor Tyrosine Kinases
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein.